Inventor · disambiguated record
Brett D. Williams
Also filed as: WILLIAMS BRETT · WILLIAMS BRETT D
5 granted patents·8 pending applications·20 citations·filing 2017–2024
74Inventor score
Top patents by PatentIndex Score
13 records- 0193US11718602B2EGFR inhibitorsBLUEPRINT MEDICINES CORP·Filed 2022·Granted Aug 8, 2023·2 cites·8 claims
- 0293US10233186B2Inhibitors of activin receptor-like kinaseBLUEPRINT MEDICINES CORP·Filed 2017·Granted Mar 19, 2019·16 cites·56 claims
- 0383US11634422B2Inhibitors of activin receptor-like kinaseBLUEPRINT MEDICINES CORP·Filed 2020·Granted Apr 25, 2023·1 cites·30 claims
- 0480US2025289801A1Egfr inhibitorsBLUEPRINT MEDICINES CORP·Filed 2024·Application pending·0 cites
- 0572US12172983B2EGFR inhibitorsBLUEPRINT MEDICINES CORP·Filed 2021·Granted Dec 24, 2024·0 cites·21 claims
- 0672US11236086B2Substituted pyrrolopyridines as inhibitors of activin receptor-like kinaseBLUEPRINT MEDICINES CORP·Filed 2018·Granted Feb 1, 2022·1 cites·19 claims
- 0760US2024368139A1Novel modulators of ehmt1 and ehmt2 and therapeutic use thereofTANGO THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0860US2024382483A1Heterocyclic egfr inhibitors for use in the treatment of cancerBLUEPRINT MEDICINES CORP·Filed 2022·Application pending·0 cites
- 0958US2024299387A1Heterocyclic egfr inhibitors for use in the treatment of cancerBLUEPRINT MEDICINES CORP·Filed 2022·Application pending·0 cites
- 1058US2024308981A1Heterocyclic egfr inhibitors for use in the treatment of cancerBLUEPRINT MEDICINES CORP·Filed 2022·Application pending·0 cites
- 1158US2024300946A1Egfr inhibitorsBLUEPRINT MEDICINES CORP·Filed 2022·Application pending·0 cites
- 1249US2022380370A1Xanthine cb1 inhibitorsGOLDFINCH BIO INC·Filed 2020·Application pending·0 cites
- 1348US2022389009A1Substituted 1,6-naphthyridine inhibitors of cdk5GOLDFINCH BIO INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Brett D. Williams files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →